补肺活血汤辅助手术治疗非小细胞肺癌临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R734.2

基金项目:


Clinical Study on Bufei Huoxue Decoction Assisting Surgery for Non-Small Cell Lung Cancer
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察补肺活血汤辅助手术治疗非小细胞肺癌的临床疗效。方法:选取104 例非小细胞肺癌 手术患者,按随机数字表法分为观察组54 例和对照组50 例。2 组均行胸腔镜肺叶切除术治疗,观察组在手术 治疗基础上加用补肺活血汤治疗。评价2 组临床疗效,比较2 组治疗前后中医证候评分、炎症因子水平及康复 指标。结果:观察组总有效率为98.15%,高于对照组84.00% (P<0.05)。术前,2 组各项中医证候评分比 较,差异无统计学意义(P>0.05)。术后,2 组各项中医证候评分较术前降低(P<0.05),且观察组各项中医 证候评分低于对照组(P<0.05)。术前,2 组降钙素原(PCT)、C-反应蛋白(CRP)、白细胞介素-6(IL-6)、 肿瘤坏死因子-α(TNF-α) 水平比较,差异无统计学意义(P>0.05)。术后,2 组PCT、CRP、IL-6、TNF-α 水平较术前升高(P<0.05),但是观察组升高幅度小于对照组(P<0.05)。观察组胸腔引流液量低于对照组, 卧床时间和住院时间短于对照组(P<0.05)。结论:补肺活血汤辅助手术治疗非小细胞肺癌,能够有效改善患 者临床症状,提高临床疗效,降低术后炎症反应,缩短患者卧床和住院时间,从而促进患者康复。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Bufei Huoxue Decoction assisting surgery for non- small cell lung cancer. Methods: A total of 104 cases of patients with non- small cell lung cancer undergoing surgery were selected and divided into the observation group and the control group according to the random number table method, with 54 and 50 cases in each group respectively. Both groups were treated with thoracoscopic lobectomy, and the observation group was additionally treated with Bufei Huoxue Decoction based on the surgery. The clinical effects in the two groups were evaluated. Traditional Chinese medicine (TCM) syndrome scores,levels of inflammatory factors and rehabilitation indexes before and after treatment in the two groups were compared. Results:The total effective rate was 98.15% in the observation group,higher than that of 84.00% in the control group (P<0.05). Before surgery,there was no significant difference being found in the comparison of TCM syndrome scores between the two groups (P>0.05). After surgery,TCM syndrome scores in the two groups were decreased when compared with those before surgery (P<0.05),and the TCM syndrome scores in the observation group were lower than those in the control group (P<0.05). Before surgery,there was no significant difference being found in the comparison of the levels of procalcitonin (PCT),C-reactive protein (CRP),interleukin-6 (IL-6) and tumor necrosis factor- α (TNF- α) between the two groups (P>0.05). After surgery, the levels of PCT, CRP, IL- 6 and TNF- α in the two groups were increased when compared with those before surgery (P<0.05), but the increasing amplitude in the observation group was smaller than that in the control group (P<0.05). The liquid volume of chest drainage in the observation group was smaller than that in the control group,and the bed rest time and the hospitalization time were shorter than those in the control group (P<0.05). Conclusion: Bufei Huoxue Decoction assisting surgery for non- small cell lung cancer can effectively improve the clinical symptoms of patients, enhance the clinical effect, reduce inflammatory responses after surgery,and shorten the bed rest time and the hospitalization time,so as to promote the recovery of patients.

    参考文献
    相似文献
    引证文献
引用本文

石东峰,徐宝川,吴晓明.补肺活血汤辅助手术治疗非小细胞肺癌临床研究[J].新中医,2023,55(3):159-162

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-02-17
  • 出版日期:
文章二维码